Educated Patient® Lung Cancer Summit

Immunotherapy Offers Certain Patients With Small Cell Lung Cancer A ‘Ray of Hope’, Expert Says

September 15th 2021

Although immunotherapy has provided patients with small cell lung cancer with a “light at the end of the tunnel,” an expert from City of Hope argues more research is needed.

Improvements in Radiation Therapy May Confer Better Treatment for Lung Cancer

September 8th 2021

Increased use of radiation in lung cancer treatment may be a result of discoveries in research and improved spreading of information on this technology.

Decreased Rates of Lung Cancer Screening Highlight Need for Greater Awareness

September 2nd 2021

More focus is needed on increasing lung cancer screening for patients, especially in those who are eligible for it according to their smoking history.

Cancer Staging: What It Means and What to Expect

August 31st 2021

New advancements in the staging process for lung cancer are leading to faster recoveries and better diagnoses.

Understanding Cancer Clinical Trials and Patient Participation

August 30th 2021

Clinical trials are an invaluable resource to the cancer community, as they continually advance treatment options for patients. An expert explains how they work and what patients should know.

Biomarker Testing in Lung Cancer Continues to Improve Outcomes, Move the Field Forward

August 27th 2021

Treating lung cancer is more precise than ever, thanks to biomarker testing, which gives clinicians a better understanding of individual’s tumors.

Educated Patient® Lung Cancer Summit Basics of Lung Cancer Session: August 14, 2021

August 14th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

Educated Patient® Lung Cancer Summit Targeted Treatment Session: August 14, 2021

August 14th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

Educated Patient® Lung Cancer Summit Looking Ahead Session: August 14, 2021

August 14th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

CURE®'s Educated Patient® Lung Cancer Summit At a Glance

April 10th 2021

Take a look back at CURE®’s Educated Patient® Lung Cancer Summit with this roundup of stories that highlight what was discussed at this half-day virtual event.

The Future of Adoptive Cellular Therapy in Lung Cancer

March 15th 2021

In the field of lung cancer, a number of current studies evaluating the efficacy of adoptive cellular therapies may one day offer patients with non-small cell lung cancer a “high risk, high reward” treatment option, according to Dr. Ben Creelan of the Moffitt Cancer Center.

Geriatric Assessment and More Inclusive Clinical Trials Needed for Older Adults with Lung Cancer

March 12th 2021

As the population ages, the incidence of older adults being diagnosed with lung cancer is increasing, though data on how to specifically treat this population are lacking.

Looking at the Big Picture of Small Cell Lung Cancer

March 10th 2021

An expert discusses ways that small cell lung cancer is diagnosed, how to treat it and how to pivot if the disease spreads or recurs. He also focuses on efforts in the clinical trial space to potentially treat patients more effectively.

Educated Patient® Lung Cancer Summit: March 6, 2021

March 6th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

How Biomarkers Impact Treatment Decisions in Lung Cancer

January 28th 2021

Biomarkers play an important role in treatment decisions of many tumors, but in lung cancer they are a deciding factor between which immunotherapy is the best option.

Communication With the Treatment Team, Self-Advocacy Play Important Roles in Small Cell Lung Cancer

January 2nd 2021

In an interview with CURE®, Dr. Wade T. Iams discussed small cell lung cancer, a subtype of lung cancer that starts from neuroendocrine cells in the lung, how different stages are treated and the potential benefits of having a treatment team to communicate with every step of the way.

Immunotherapy Side Effects: Know What to Look For

December 22nd 2020

Dr. Sally J. York goes over the types of immunotherapy-related side effects, and what patients with lung cancer and their caregivers should look out for.